Scalp TX-1 Laser
Androgenetic alopecia(male pattern baldness) (AGA) is a common condition affecting both men and women. In the case of men, up to 30% over the age of 30 and more than 50% over the age of 50 are affected. AGA also affects women although clinical signs are usually milder and associated with diffuse thinning of the scalp hair.
Telogen effluvium is a hair loss condition whereby there is a sudden generalized loss of large amount of hair after a stressful event i.e. childbirth, severe illness or surgery. The person notices that it comes out ‘in handfuls’, especially after being brushed or washed and that the pillow case is covered in hairs in the morning. The condition normally resolves uneventfully after 3-4months. Treatment is usually conservative and lasers have been used to treat this condition.
By far the most promising approaches to the treatment of baldness in men are drug therapies, such as topical minoxidil and finasteride administered systemically. Mild to moderate AGA in women can be treated with antiandrogens and/or topical minoxidil with good results in many cases.
What is low level laser treatment?
Low Level Lasers are also known as “cold” lasers because they do not release energy in the form of heat. The light wavelength is emitted at a low level to repair tissues by stimulating blood circulation, encouraging regeneration of normal healthy tissues.
Exposure to low-level laser light can stimulate cell function leading to beneficial effects.
How does it work?
Low level laser light is absorbed by cells and stimulates cell metabolism and protein production. Although the exact mechanism by which laser light promotes hair growth is still unknown, it appears to stimulate the follicles on the scalp by increasing energy production and by reversing miniaturization (the process leading to thicker hair shafts and a fuller look).
The visible red light is absorbed by the cells and the process of cell repair begins. One theory of how this works is that it stimulates the production of energy at the cell level; therefore, improving cell function. It is believed that LLLT may increase blood flow to the treated area as well.
What are it’s clinical applications?
The biomodulating effects of low-level laser light on human cells has been adapted to medical uses such as enhanced wound healing and treatment of some types of pain, and to cosmetic uses associated with effects on human skin.
Low-level laser light has also been found to have biomodulating effects on human hair and hair follicles.
Clinical applications include treating soft tissue injury, chronic pain, wound healing and nerve regeneration.
Low-level laser medical therapy is currently approved by the FDA for treatment of carpal tunnel syndrome and for relief of discomfort.
What is the clinical evidence?
Low energy lasers have been used for over thirty years to accelerate healing after wounds or burns and to reduce pain. In 1992, Pontinen published the first paper discussing its possible use in promoting hair growth. Since then there has been much progress is defining the exact parameters necessary to accomplish this, In 2007, the FDA cleared for marketing the use of low-level lasers for the treatment of androgenetic hair loss in men. This clearance was based on the device’s safety, and not on its effectiveness in treating hair loss.
In January of 2007, the FDA granted clearance to the first hand-held low level laser device for the treatment of hair growth. In the FDA summary, the FDA noted that the low level laser device was capable of promoting hair growth in men with ‘androgenetic alopecia’ (male pattern hair loss).
Low-level laser therapy devices for hair restoration i.e. HairMAX LaserComb, is accepted as a Medical Device in Canada, and is allowed to make therapeutic claims that it (1) increases strength of scalp hair in men and women, (2) prevents scalp hair loss in men and women, and (3) causes regrowth of scalp hair in men and women.
In Jan 2007 the Food and Drug Administration (FDA) approved its use as a Cosmetic Laser Product in.for the treatment of Androgenetic Alopecia(male pattern hair loss). Approval by the FDA as a Medical Device is pending while appropriate clinical trials are completed.
The Revage 670 Laser is a safe and painless laser system that has been FDA approved as a cosmetic product and has met the international laser standard for safety. Studies with the device have shown that the low level laser produces an 85% success rate in halting the progression of hair loss and up to a 39% increase in fullness.
The Scalp TX-1 is a low level light laser for treating hair loss that is manufactured in Korea. It uses a combination of red and infrared light to improve microcirculation to the hair follicles on the scalp and stimulate hair growth.
European studies have shown that LLLT stops hair loss in 85% of cases and stimulates new hair growth in 55% of cases. Laser therapy has been safely used for decades throughout Europe, the Far East and has no documented side effects.
How does the treatment feel like?
LLLT is delivered by a device that contains panels of lasers that shine on the scalp. With LLLT, there is no cutting or burning sensation
Men and women being treated for hair loss sit comfortably under the lasers as it gently delivers the phototherapy to the scalp. Most of our patients read a magazine during treatments. There is no pain or discomfort from the therapy–some patients do report some “scalp-tingling”.
How many treatments?
Treatments are administered twice per week for 6 weeks and then once a week for the next 16 weeks. Once hair growth has been observed, periodic touch-ups may be needed to maintain the benefits of the treatment. Each treatment session takes approximately 30 minutes.
What are results?
Patients who have used the therapy have said that their hair looks and feels thicker, fuller and healthier and they have noticed improved hair growth. Laser Therapy is no ‘miracle cure’ for hair loss. For best results, a visit can evaluate your condition, make treatment recommendations and evaluate your progress, is highly recommended. The Highest degree of satisfaction is obtained when a patient’s expectations are closely in-line with what the treatment can realistically provide.